在患有多种并发症的患者中治疗中风后
Marilena Mangiardi1, Gianmarco Iaccarino2, Michele Alessiani2
1Stroke Unit, Azienda Ospedaliera San Camillo Forlanini, Rome, ITA.
卒中是成年人发作的主要原因之一. 管理中风后的发作,特别是在患有并发症的老年患者中,由于缺乏明确的抗药物治疗指南,因此存在重大挑战.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 脑卒中是成年人发作和的主要原因.
- 与中风相关的的危险因素包括中风严重程度,年轻年龄,出血性中风和酒精使用.
研究的目的:
- 突出治疗中风后发作的复杂性,特别是患有并发症的老年患者.
- 强调需要对抗发作药物 (ASM) 治疗中风后发作提供更明确的指导方针.
主要方法:
- 一个77岁的男性的病例介绍,他患有牛皮脂溶解和糖尿病,经历了缺血性中风和随后的发作.
- 关于中风后发作管理的当前文献和指导方针的审查.
主要成果:
- 该案例说明了选择最佳抗发作药物 (ASM),预防策略和ASM戒断在有多种健康问题的老年人中的挑战.
- 目前的指导方针缺乏针对中风后发作治疗的具体建议,这使得临床决策复杂化.
结论:
- 老年患者中风后发作的有效管理需要仔细考虑并发症,多药性和改变的药理动力学.
- 需要基于证据的指导方针来优化中风后发作的治疗.
更多相关视频
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
相关概念视频
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
